PLSE Pulse Biosciences
- 8.030
- +0.430+5.66%
Pulse Biosciences News
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
HAYWARD, Calif.--(BUSINESS WIRE)--May 2, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablatio
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
HAYWARD, Calif.--(BUSINESS WIRE)--Apr. 24, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, tod
After the Recent Decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's Holdings Have Lost 13% of Their Value
Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable ownership 68% of the company is held by a single shareholder (Robert Duggan) Using da
Pulse Biosciences to Sell Subscription Rights to Purchase up to 6M Units
Pulse Biosciences Shares Fall After Q4 Results, Rights Issue Plans
Pulse Biosciences (PLSE) shares fell more than 13% in recent Monday trading following its Q4 results late last week and plans to raise funds through a rights issue. Late Thursday, the company reported
Precision Biosciences, Mesoblast, Pulse Biosciences Among Healthcare Movers
Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects PVH Corp. (NYSE:PVH) to report quarterly earn
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million. Sunshine Biopharma (NASDAQ:SB
Pulse Biosciences to Raise $60M
Q4 2023 Pulse Biosciences Inc Earnings Call
Earnings Call Summary | Pulse Biosciences(PLSE.US) Q4 2023 Earnings Conference
The following is a summary of the Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript:Financial Performance:Pulse Biosciences reported an increase in its Non-GAAP total costs and expenses, r
Pulse Biosciences Inc (PLSE) Reports Increased GAAP Costs and Narrowed Net Loss in 2023
Pulse Biosciences Files for $50M Mixed Securities Shelf
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. The company's market cap stands at $39.3 million. Sunshine Biopharma (NASDAQ:SBFM) sha
Pulse Biosciences to Initiate Rights Offering of Up To $60M Worth of Units >PLSE
Pulse Biosciences to Initiate Rights Offering of Up To $60M Worth of Units >PLSE
Pulse Biosciences GAAP EPS of -$0.22
Pulse Biosciences 4Q Loss/Shr 22c >PLSE
Pulse Biosciences 4Q Loss/Shr 22c >PLSE
Press Release: Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results HAYWARD, Calif.--(BUSINESS WIRE)--March 28, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated
Pulse Biosciences Announces Plans to Initiate a Rights Offering
HAYWARD, Calif.--(BUSINESS WIRE)--Mar. 28, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, tod
Analysis
Price Target
No Data
